Found: 23
Select item for more details and to access through your institution.
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 7784, doi. 10.1002/cam4.5536
- By:
- Publication type:
- Article
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 6, p. 1039, doi. 10.1007/s10120-022-01325-6
- By:
- Publication type:
- Article
A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines.
- Published in:
- Journal of Gastric Cancer, 2022, v. 22, n. 1, p. 3, doi. 10.5230/jgc.2022.22.e10
- By:
- Publication type:
- Article
Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial).
- Published in:
- Gastric Cancer, 2021, v. 24, n. 1, p. 156, doi. 10.1007/s10120-020-01101-4
- By:
- Publication type:
- Article
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1206, doi. 10.1007/s10120-019-00958-4
- By:
- Publication type:
- Article
Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 453, doi. 10.1007/s10120-017-0756-z
- By:
- Publication type:
- Article
Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis.
- Published in:
- Journal of Gastric Cancer, 2018, v. 18, n. 1, p. 69, doi. 10.5230/jgc.2018.18.e9
- By:
- Publication type:
- Article
Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial.
- Published in:
- Journal of Gastric Cancer, 2017, v. 17, n. 2, p. 120, doi. 10.5230/jgc.2017.17.e15
- By:
- Publication type:
- Article
Efficacy and Safety of FOLFIRI Regimen in Elderly Patients with Metastatic Colorectal or Gastric Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 3, p. 293, doi. 10.1634/theoncologist.2016-0166
- By:
- Publication type:
- Article
A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 2, p. 586, doi. 10.1007/s10120-015-0490-3
- By:
- Publication type:
- Article
Postgastrectomy pharmacokinetic changes of S-1 in patients with localized advanced gastric cancer.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 8, p. 926, doi. 10.1002/jcph.499
- By:
- Publication type:
- Article
Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 896, doi. 10.1634/theoncologist.2015-0202
- By:
- Publication type:
- Article
Erratum to: Prognostic Impact of Microscopic Tumor Involved Resection Margin in Advanced Gastric Cancer Patients after Gastric Resection.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Prognostic Impact of Microscopic Tumor Involved Resection Margin in Advanced Gastric Cancer Patients after Gastric Resection.
- Published in:
- World Journal of Surgery, 2014, v. 38, n. 2, p. 439, doi. 10.1007/s00268-013-2301-5
- By:
- Publication type:
- Article
Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 5, p. 953, doi. 10.1007/s00280-013-2272-0
- By:
- Publication type:
- Article
Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer.
- Published in:
- Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 9, p. 1489, doi. 10.1111/jgh.12262
- By:
- Publication type:
- Article
Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2011, v. 25, n. 5, p. 1505, doi. 10.1007/s00464-010-1426-y
- By:
- Publication type:
- Article
Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 127, doi. 10.1007/s00280-010-1296-y
- By:
- Publication type:
- Article
Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 12, p. 3163, doi. 10.1245/s10434-010-1164-3
- By:
- Publication type:
- Article
Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 889, doi. 10.1007/s00280-009-1235-y
- By:
- Publication type:
- Article
Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 3, p. 579, doi. 10.1007/s00280-009-1067-9
- By:
- Publication type:
- Article
A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
A Phase II Study of VP-16-Ifosfamide-Cisplatin Combination Chemotherapy Plus Early Concurrent Thoracic Irradiation for Previously Untreated Limited Small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2000, v. 30, n. 12, p. 542, doi. 10.1093/jjco/hyd135
- By:
- Publication type:
- Article